Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
60.9M
-
Number of holders
-
37
-
Total 13F shares, excl. options
-
6.92M
-
Shares change
-
-783K
-
Total reported value, excl. options
-
$37M
-
Value change
-
-$4.86M
-
Number of buys
-
25
-
Number of sells
-
-15
-
Price
-
$5.35
Significant Holders of Equillium, Inc. - Common Stock (EQ) as of Q4 2020
47 filings reported holding EQ - Equillium, Inc. - Common Stock as of Q4 2020.
Equillium, Inc. - Common Stock (EQ) has 37 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.92M shares
of 60.9M outstanding shares and own 11.36% of the company stock.
Largest 10 shareholders include VICTORY CAPITAL MANAGEMENT INC (2.24M shares), Samsara BioCapital, LLC (1.07M shares), FARALLON CAPITAL MANAGEMENT LLC (700K shares), FRANKLIN RESOURCES INC (700K shares), VANGUARD GROUP INC (601K shares), TANG CAPITAL MANAGEMENT LLC (600K shares), FMR LLC (210K shares), BRIDGEWAY CAPITAL MANAGEMENT, LLC (102K shares), MORGAN STANLEY (78.8K shares), and BlackRock Inc. (69.2K shares).
This table shows the top 37 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.